|Articles|January 14, 2014

CVD May Increase Risk of Cognitive Decline in Older Women

The results of a recent study identified a relationship between cardiovascular disease and cognitive decline in postmenopausal women.

A relationship between cardiovascular disease (CVD) and cognitive decline in postmenopausal women was identified in a recent study published online in the Journal of the American Heart Association. In women without CVD, hypertension and diabetes increased the risk for cognitive decline. No significant relationship was found between atrial fibrillation and heart failure with cognitive functioning.

To read the full article at HCPLive.com, click here.

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Latest CME

Virtual Symposium Registration

Evolving Treatment Options in Plaque Psoriasis: Implications of Emerging TYK2 Inhibitors for Managed Care

Thursday, September 10, 2026 | 7:00 AM – 8:00 AM EDT

Virtual Event

PBMI 2026

September 10 - September 11, 2026

Virtual Event

Lung Cancer Day of Education 2026

Monday, October 26, 2026

Virtual Event

Specialty Pharmacy Day of Education 2026

Thursday, November 5, 2026

CVD May Increase Risk of Cognitive Decline in Older Women

Related Content

High-Dose Influenza Vaccine Lowers Hospitalization Risk in Older Adults With Chronic Lung Disease

Arlo-Cel Meets Response End Points in Heavily Pretreated Myeloma

Impact of a Structured, Accredited Pharmacy Technician Education and Training Program on Workforce Retention

Sensing Inequity: How Students Can Expand CGM Access

In-Hospital Dapagliflozin Speeds Decongestion in Heart Failure

Latest CME

Evolving Treatment Options in Plaque Psoriasis: Implications of Emerging TYK2 Inhibitors for Managed Care

PBMI 2026

Lung Cancer Day of Education 2026

Specialty Pharmacy Day of Education 2026

From Payload to Patient: Managing Toxicities of Antibody-Drug Conjugates Directed at HER2 and TROP2

Exploring Immunotherapy Strategies in Endometrial Cancer

Pharmacogenomics in Practice: Enhancing Patient Care Through Genetic Insights

New Oncology Therapy Approvals for 2025 (Pharmacist Credit)

Navigating Novel Therapies in Steroid-Refractory cGVHD: Practical Strategies for Community-Based Oncology Pharmacists

The Pharmacist's Role in Palliative and End of Life Symptom Management

Reducing the Treatment Burden in HIV Management: The Pharmacist’s Role in Long-Acting Injectable Adoption

Optimizing Lipid Management in Statin-Intolerant Populations: Payer Strategies for Evidence-Based Access and Risk Reduction

New Horizons in ATTR-CM: Therapeutic Advances and Strategic Insights

Transforming Gout Care: Navigating Barriers and Therapeutic Advances in Disease Management

Looking at Patient-Centered Care in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema Through a Value-Based Lens

The Pharmacist's Role in Palliative and End of Life Symptom Management (Pharmacy Technician Credit)

Optimizing Antibody-Drug Conjugate Safety: Pharmacist Strategies for Grading, Monitoring, and Supportive Care

Transforming Generalized Myasthenia Gravis Care: The Evolving Role of Pharmacists in Optimizing Therapy and Long-Term Disease Management

Access and Formulary Design Considerations for Nonsteroidal Topical Therapies in Dermatology

Evolving Care in IgA Nephropathy: Translating Emerging Evidence Into Care

Evolving Hidradenitis Suppurativa Management: Advancements in Treatment and Managed Care Integration Across Patient Populations

Directions in Oncology Pharmacy® 2026

Directions in Oncology Pharmacy® 2026 Northeast

2025 SABCS Abstracts to Action: From Data to Decisions in HR+ Breast Cancer Care

NEIAP Conference 2026

New Treatments in Systemic Lupus Erythematosus to Advance Care: A Managed Care Focus on Nephritis

Directions in Oncology Pharmacy® 2026 Midwest

Shingles Vaccination: Opportunities for Pharmacist Interventions to Provide Patient Education

Infectious Disease Day of Education 2026

Continuing the Conversation—Breaking Barriers in Obesity Management: Localizing Care, Maximizing Treatment Access, and Sustaining Adherence

The Educated Pharmacist: Overcoming Clinical Inertia—An Interactive Case Workshop for Optimizing Insulin Use

Navigating the Complexities of Personalized Prostate Cancer Care: Insights for Oncology Managed Care

Advancing HER2-Driven Cancer Care, Biomarker Testing, and Pharmacist Innovation

Navigating Outpatient Bispecific Antibody Administration in Lymphoma: Practical Solutions for Community Oncology Practices

Infectious Disease Day of Education 2026

Innovations in Narcolepsy Treatment: Emerging Targets and Implications for Managed Care

NEIAP 2026 Annual Forum

Lymphoma Day of Education 2026

Reducing Transfusion Burden in Myeloid Disorders: Novel Therapeutic Strategies and Pharmacist Interventions

Panel Discussion: Integrating Novel Combinations and Earlier Line Use in Diffuse Large B-Cell Lymphoma

Optimizing Patient Outcomes in R/R DLBCL: Bridging Knowledge Gaps for Oncology Pharmacists in the Era of Novel Immunotherapies

Clinical Panel Debate: CAR T-Cell Therapy vs Bispecific Antibodies

From Molecules to Medicine: Pharmacologic Principles of Innovative Non-Hodgkin Lymphoma Therapies

Understanding mRNA Vaccines: Dispelling Myths and Empowering Pharmacists to Counsel Patients (Pharmacy Technician Credit)

Understanding mRNA Vaccines: Dispelling Myths and Empowering Pharmacists to Counsel Patients

Directions in Oncology Pharmacy® 2026 Southeast

Precision Matters: Foundations of Biomarker-Driven Care in Non-Small Cell Lung Cancer

Navigating the Legal Landscape of Telehealth: Updates and Implications for Pharmacists and Technicians

From Testing to Treatment: Empowering Pharmacists to Overcome Barriers and Optimize Biomarker-Driven Care

Navigating the Legal Landscape of Telehealth: Updates and Implications for Pharmacists and Technicians (Pharmacy Technician Credit)

Exploring Oncolytic Viruses in Melanoma: Pharmacist-Led Approaches for Safe Integration

Clinical Presentation of Hyperglycemia with PI3K and AKT Inhibitors

Directions in Oncology Pharmacy® 2026 West Coast

Addressing Vaccine Hesitancy in Infectious Disease Prevention

Protecting Against Meningococcal Disease: Updates on Vaccines, Guidelines, and Pharmacist Best Practices

ASCP 2026

Targeting the Root of Autoimmunity in Generalized Myasthenia Gravis: Pharmacist Strategies for Integrating FcRn Therapies Into Specialty Practice

IL-23 Inhibitors in Psoriasis: Optimizing Access and Patient Outcomes Across Integrated Systems

Utilizing VMAT-2 Inhibitors for the Management of Tardive Dyskinesia: The Role of Long-Term Care Pharmacists

The Expanding Therapeutic Landscape in IgA Nephropathy: Translating New Clinical Evidence and Updated Guidelines Into Managed Care Strategies

The Expanding Therapeutic Landscape in IgA Nephropathy: A Case-Based Exploration of Optimized Patient Outcomes

Influenza Immunization in Older Adults: Enhanced Vaccines and Best Practices for Long-Term Care Pharmacists

From Guidelines to Action: Implementing Pneumococcal Vaccine ACIP Recommendations in Long-Term Care Settings

Specialty Pharmacy Day of Education 2026

Multidisciplinary Insights and Strategies for Patients Treated With PI3K and AKT Inhibitors to Prevent Hyperglycemia

Innovations in Retinal Therapies: A Managed Care Perspective on Anti-VEGF Advancements

Navigating Advanced Prostate Cancer Treatment: Optimizing Novel Therapeutic Strategies for Managed Care Pharmacists

Cardiorenal Protection With SGLT2 Inhibitors: Perspectives for Managed Care

Bridging Innovation and Access in HR-Positive/HER2-Negative Metastatic Breast Cancer: Implications for Managed Care

Effective Strategies to Manage Hyperglycemia When Treating with PI3K and AKT Inhibitors

Multidisciplinary Insights to Enhance Biomarker Testing Practices in Non-Small Cell Lung Cancer

Addressing Gaps in Care for the Rapid and Long-Term Management of Hyperkalemia With Novel Oral Potassium Binding Agents: Insights for Managed Care Professionals